Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1458981Generated: October 26, 2026

1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1-propanone hydrochloride → 1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]-1-trans-propene hydrochloride

https://huagongshe.com/reaction/1458981

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1-propanone hydrochlorideHCID 22097301—
Reactant1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1-trans-propene hydrochlorideHCID 22097305—
Reactant1-(2-Chloro-3-methylphenyl)piperazine hydrochlorideHCID 22097307—
Product1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]-1-trans-propene hydrochlorideHCID 22097288—

Reaction Steps

The procedures of Example 6 (1) and (2) were repeated but substituting the 1,2,3,4-tetrahydroisoquinoline hydrochloride employed in Example 6 (1) by 680 mg of 1-(2-chloro-3-methylphenyl)piperazine hydrochloride. After the completion of the post treatment, 93 mg of the title compound was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05852019
Source datasetuspto-grants-1998_12
ORD IDord-297b725949fc46828f4158e9f61253de
Source noteuspto-grants-1998_12